We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

131 hedge funds and large institutions have $1.68B invested in Arcus Biosciences in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $4.84M | Put options by funds: $1.37M

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

36% more capital invested

Capital invested by funds: $1.24B → $1.68B (+$445M)

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

4% more ownership

Funds ownership: 63.62% → 67.62% (+4%)

1% more funds holding

Funds holding: 130 → 131 (+1)

29% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 51

Holders
131
Holders Change
+1
Holders Change %
+0.77%
% of All Funds
2.29%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
17
Increased
36
Reduced
51
Closed
15
Calls
$4.84M
Puts
$1.37M
Net Calls
+$3.47M
Net Calls Change
+$8.16M

Top Buyers

1
EC
EcoR1 Capital
California
+$55.6M
2
Franklin Resources
Franklin Resources
California
+$18.1M
3
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$14.7M
4
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$14.2M
5
BI
BVF Inc
California
+$13.4M

Top Sellers

1
AI
Alphabet Inc
California
-$16M
2
Goldman Sachs
Goldman Sachs
New York
-$11.1M
3
State Street
State Street
Massachusetts
-$11M
4
Renaissance Technologies
Renaissance Technologies
New York
-$7.57M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
126
Lindbrook Capital
California
$2K – – –
MGIM
127
M&G Investment Management
United Kingdom
$1.46K +$1.3M +41,631 New
BIA
128
Bell Investment Advisors
California
$1K +$560 +18 New
Nisa Investment Advisors
129
Nisa Investment Advisors
Missouri
$85 – – –
Renaissance Technologies
130
Renaissance Technologies
New York
– -$7.57M -275,700 Closed
Walleye Capital
131
Walleye Capital
New York
– -$2.37K -86,438 Closed
Fidelity International
132
Fidelity International
Bermuda
– -$1M -36,441 Closed
Walleye Trading
133
Walleye Trading
New York
– -$919K -33,479 Closed
MCM
134
Moore Capital Management
New York
– -$687K -25,000 Closed
Norges Bank
135
Norges Bank
Norway
– -$549K -20,000 Closed
Russell Investments Group
136
Russell Investments Group
United Kingdom
– -$287K -10,540 Closed
VRS
137
Virginia Retirement Systems
Virginia
– -$286K -10,400 Closed
Los Angeles Capital Management
138
Los Angeles Capital Management
California
– -$277K -10,085 Closed
Credit Agricole
139
Credit Agricole
France
– -$170K -6,200 Closed
Acadian Asset Management
140
Acadian Asset Management
Massachusetts
– -$137K -5,022 Closed
FC
141
FORA Capital
Florida
– -$134K -4,874 Closed
Royal Bank of Canada
142
Royal Bank of Canada
Ontario, Canada
– -$85K -3,102 Closed
Northwestern Mutual Wealth Management
143
Northwestern Mutual Wealth Management
Wisconsin
– -$72K -2,314 -100%
S
144
SignatureFD
Georgia
– -$1K -26 Closed
2 3 4 5
6

RCUS Hedge Fund Activity: Q3 2021 in Review

131 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q3 2021, worth a combined $1.68B — up 36% from $1.24B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new RCUS positions and 15 closed out — a net gain of 2 holders — while 36 added to existing stakes and 51 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $55.6M. The largest seller was Alphabet Inc, cutting an estimated $16M.

  • 131 institutional investors held Arcus Biosciences (RCUS) as of Q3 2021, up from 130 in Q2 2021.
  • Funds reported $1.68B of Arcus Biosciences stock for Q3 2021, up 36% quarter-over-quarter.
  • 17 funds opened new Arcus Biosciences positions in Q3 2021 and 15 closed out, a net change of +2 holders.
  • The largest Arcus Biosciences buyer in Q3 2021 was EcoR1 Capital, an estimated $55.6M added.
  • The largest Arcus Biosciences seller in Q3 2021 was Alphabet Inc, an estimated $16M sold.

Based on aggregated 13F filings for Q3 2021.